{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T04:59:15Z","timestamp":1777438755262,"version":"3.51.4"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T00:00:00Z","timestamp":1746144000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T00:00:00Z","timestamp":1746144000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Cancer cells reprogram their energy metabolism pathways, but the mechanisms that enable them to meet their energy demands remain poorly understood. This study investigates the anticancer effects of ethyl <jats:italic>p<\/jats:italic>-methoxycinnamate (EMC) in Ehrlich ascites tumor cells (EATCs) and reveals that <jats:italic>de novo<\/jats:italic> fatty acid synthesis, rather than glycolysis, plays a pivotal role in sustaining energy homeostasis in cancer cells. EMC significantly reduced ATP levels despite enhancing glycolytic activity. It suppressed the expression of key enzymes involved in <jats:italic>de novo<\/jats:italic> fatty acid synthesis, including <jats:italic>Acly<\/jats:italic>, <jats:italic>Acc1<\/jats:italic>, and <jats:italic>Fasn<\/jats:italic>, resulting in decreased intracellular triglyceride (TG) levels. The addition of exogenous palmitic acid reversed EMC-induced ATP depletion and mitigated its anti-proliferative effects. Mechanistically, the ATP reduction caused by EMC was associated with inhibition of the c-Myc\/SREBP1 pathway and arrest of the G1\/S cell cycle transition. These findings demonstrate that EMC inhibits EATC proliferation by reducing ATP levels via suppression of <jats:italic>de novo<\/jats:italic> fatty acid synthesis. This study highlights the critical role of <jats:italic>de novo<\/jats:italic> fatty acid synthesis, rather than glycolysis, in maintaining energy homeostasis in cancer cells and provides novel insights into targeting cancer metabolism.<\/jats:p>","DOI":"10.1038\/s41598-025-00131-1","type":"journal-article","created":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T02:22:30Z","timestamp":1746152550000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Ethyl p-methoxycinnamate inhibits tumor growth by suppressing of fatty acid synthesis and depleting ATP"],"prefix":"10.1038","volume":"15","author":[{"given":"Yutaro","family":"Sasaki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Niina","family":"Mizushima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshio","family":"Norikura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isao","family":"Matsui-Yuasa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8167-3693","authenticated-orcid":false,"given":"Akiko","family":"Kojima-Yuasa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,5,2]]},"reference":[{"key":"131_CR1","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.tcb.2016.08.009","volume":"27","author":"M Salazar-Roa","year":"2017","unstructured":"Salazar-Roa, M. & Malumbres, M. Fueling the cell division cycle. Trends Cell. Biol. 27, 69\u201381. https:\/\/doi.org\/10.1016\/j.tcb.2016.08.009 (2017).","journal-title":"Trends Cell. Biol."},{"key":"131_CR2","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1038\/s12276-023-01020-1","volume":"55","author":"X Xu","year":"2023","unstructured":"Xu, X. et al. Metabolic reprogramming and epigenetic modifications in cancer: from the impacts and mechanisms to the treatment potential. Exp. Mol. Med. 55, 1357\u20131370. https:\/\/doi.org\/10.1038\/s12276-023-01020-1 (2023).","journal-title":"Exp. Mol. Med."},{"key":"131_CR3","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1126\/science.123.3191.309","volume":"123","author":"O Warburg","year":"1956","unstructured":"Warburg, O. On the origin of cancer cells. Science 123, 309\u2013314. https:\/\/doi.org\/10.1126\/science.123.3191.309 (1956).","journal-title":"Science"},{"key":"131_CR4","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1007\/BF01726240","volume":"5","author":"O Warburg","year":"1926","unstructured":"Warburg, O., Wind, F. & Negelein, E. Ueber Den Stoffwechsel von tumoren Im K\u00f6rper. Klin. Wochenschr. 5, 829\u2013832. https:\/\/doi.org\/10.1007\/BF01726240 (1926).","journal-title":"Klin. Wochenschr"},{"key":"131_CR5","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.mam.2009.12.004","volume":"31","author":"V Gogvadze","year":"2010","unstructured":"Gogvadze, V., Zhivotovsky, B. & Orrenius, S. The Warburg effect and mitochondrial stability in cancer cells. Mol. Aspects Med. 31, 60\u201374. https:\/\/doi.org\/10.1016\/j.mam.2009.12.004 (2010).","journal-title":"Mol. Aspects Med."},{"key":"131_CR6","doi-asserted-by":"publisher","first-page":"4633","DOI":"10.1038\/sj.onc.1209597","volume":"25","author":"H Pelicano","year":"2006","unstructured":"Pelicano, H., Martin, D., Xu, R., Huang, P. & & Glycolysis Inhibition for anticancer treatment. Oncogene 25, 4633\u20134646. https:\/\/doi.org\/10.1038\/sj.onc.1209597 (2006).","journal-title":"Oncogene"},{"key":"131_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1476-4598-12-152","volume":"12","author":"S Ganapathy-Kanniappan","year":"2013","unstructured":"Ganapathy-Kanniappan, S. & Geschwind, J. F. H. Tumor Glycolysis as a target for cancer therapy: progress and prospects. Mol. Cancer. 12, 1\u201311. https:\/\/doi.org\/10.1186\/1476-4598-12-152 (2013).","journal-title":"Mol. Cancer"},{"key":"131_CR8","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/j.bbrc.2003.11.136","volume":"313","author":"XL Zu","year":"2004","unstructured":"Zu, X. L. & Guppy, M. Cancer metabolism: facts, fantasy, and fiction. Biochem. Biophys. Res. Commun. 313, 459\u2013465. https:\/\/doi.org\/10.1016\/j.bbrc.2003.11.136 (2004).","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"Pt2","key":"131_CR9","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.semcancer.2022.07.005","volume":"86","author":"H Lee","year":"2022","unstructured":"Lee, H., Woo, S. M., Jang, H., Kang, M. & Kim, S. Y. Cancer depends on fatty acids for ATP production: A possible link between cancer and obesity. Semin Cancer Biol. 86 (Pt2), 347\u2013357. https:\/\/doi.org\/10.1016\/j.semcancer.2022.07.005 (2022).","journal-title":"Semin Cancer Biol."},{"key":"131_CR10","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.addr.2020.07.013","volume":"159","author":"LM Butler","year":"2020","unstructured":"Butler, L. M. et al. Lipids and cancer: emerging roles in pathogenesis, diagnosis and therapeutic intervention. Adv. Drug Deliv Rev. 159, 245\u2013293. https:\/\/doi.org\/10.1016\/j.addr.2020.07.013 (2020).","journal-title":"Adv. Drug Deliv Rev."},{"key":"131_CR11","first-page":"27","volume":"13","author":"G Medes","year":"1953","unstructured":"Medes, G., Thomas, A. & Weinhouse, S. Metabolism of neoplastic tissue. IV. A study of lipid synthesis in neoplastic tissue slices in vitro. Cancer Res. 13, 27\u201329 (1953).","journal-title":"Cancer Res."},{"key":"131_CR12","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1038\/nrc2222","volume":"7","author":"JA Menendez","year":"2007","unstructured":"Menendez, J. A. & Lupu, R. Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis. Nat. Rev. Cancer. 7, 763\u2013777. https:\/\/doi.org\/10.1038\/nrc2222 (2007).","journal-title":"Nat. Rev. Cancer"},{"key":"131_CR13","doi-asserted-by":"publisher","unstructured":"Ma, X. & Wang, Z. Anticancer drug discovery in the future: an evolutionary perspective. Drug Discov. Today, 14, 1136\u20131142. https:\/\/doi.org\/10.1016\/j.drudis.2009.09.006 (2009).","DOI":"10.1016\/j.drudis.2009.09.006"},{"key":"131_CR14","doi-asserted-by":"publisher","first-page":"3494","DOI":"10.3390\/molecules26123494","volume":"26","author":"AS Dias","year":"2021","unstructured":"Dias, A. S., Helguero, L., Almeida, C. R. & Duarte, I. F. Natural compounds as metabolic modulators of the tumor microenvironment. Molecules 26, 3494. https:\/\/doi.org\/10.3390\/molecules26123494 (2021).","journal-title":"Molecules"},{"key":"131_CR15","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.omto.2021.08.015","volume":"23","author":"T Wang","year":"2021","unstructured":"Wang, T., Ma, F. & Qian, H.-l. Defueling the cancer: ATP synthase as an emerging target in cancer therapy. Mol. Ther. -Oncolytics. 23, 82\u201395. https:\/\/doi.org\/10.1016\/j.omto.2021.08.015 (2021).","journal-title":"Mol. Ther. -Oncolytics"},{"key":"131_CR16","doi-asserted-by":"publisher","first-page":"012057","DOI":"10.1088\/1755-1315\/819\/1\/012057","volume":"819","author":"NPE Hikmawanti","year":"2021","unstructured":"Hikmawanti, N. P. E. & Dwita, L. P. Chemical component of Kencur (kaemferia Galanga L.) ethanolic extract using gas chromatography-mass spectrometry. IOP Conf. Ser. Earth Environ. Sci. 819, 012057. https:\/\/doi.org\/10.1088\/1755-1315\/819\/1\/012057 (2021).","journal-title":"IOP Conf. Ser. Earth Environ. Sci."},{"key":"131_CR17","doi-asserted-by":"publisher","first-page":"11309","DOI":"10.1021\/jf304169j","volume":"60","author":"ZH He","year":"2012","unstructured":"He, Z. H., Yue, G. G. L., Lau, C. B. S., Ge, W. & But, P. P. H. Antiangiogenic effects and mechanisms of trans-ethyl p-methoxycinnamate from Kaempferia galanga L. J. Agric. Food Chem. 60, 11309\u201311317. https:\/\/doi.org\/10.1021\/jf304169j (2012).","journal-title":"J. Agric. Food Chem."},{"key":"131_CR18","doi-asserted-by":"publisher","first-page":"e17588","DOI":"10.1016\/j.heliyon.2023.e17588","volume":"9","author":"Y Sasaki","year":"2023","unstructured":"Sasaki, Y. et al. Kaempferia galanga L. extract and its main component, Ethyl p-methoxycinnamate, inhibit the proliferation of Ehrlich Ascites tumor cells by suppressing TFAM expression. Heliyon 9, e17588. https:\/\/doi.org\/10.1016\/j.heliyon.2023.e17588 (2023).","journal-title":"Heliyon"},{"key":"131_CR19","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1038\/s41416-019-0451-4","volume":"120","author":"R Munir","year":"2019","unstructured":"Munir, R., Lisec, J., Swinnen, J. V. & Zaidi, N. Lipid metabolism in cancer cells under metabolic stress. Br. J. Cancer. 120, 1090\u20131098. https:\/\/doi.org\/10.1038\/s41416-019-0451-4 (2019).","journal-title":"Br. J. Cancer"},{"key":"131_CR20","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1007\/s10555-023-10156-5","volume":"43","author":"F Su","year":"2024","unstructured":"Su, F. & Koeberle, A. Regulation and targeting of SREBP-1 in hepatocellular carcinoma. Cancer Metastasis Rev. 43, 673\u2013708. https:\/\/doi.org\/10.1007\/s10555-023-10156-5 (2024).","journal-title":"Cancer Metastasis Rev."},{"key":"131_CR21","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.cmet.2019.11.010","volume":"31","author":"MT Snaebjornsson","year":"2020","unstructured":"Snaebjornsson, M. T., Janaki-Raman, S. & Schulze, A. Greasing the wheels of the cancer machine: the role of lipid metabolism in cancer. Cell. Metab. 31, 62\u201376. https:\/\/doi.org\/10.1016\/j.cmet.2019.11.010 (2020).","journal-title":"Cell. Metab."},{"key":"131_CR22","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/s1388-1981(00)00140-2","volume":"1529","author":"PA Edwards","year":"2000","unstructured":"Edwards, P. A., Tabor, D., Kast, H. R. & Venkateswaran, A. Regulation of gene expression by SREBP and SCAP. Biochim. Biophys. Acta Mol. Cell. Biol. Lipids. 1529, 103\u2013113. https:\/\/doi.org\/10.1016\/s1388-1981(00)00140-2 (2000).","journal-title":"Biochim. Biophys. Acta Mol. Cell. Biol. Lipids"},{"key":"131_CR23","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.canlet.2020.12.019","volume":"502","author":"J Chen","year":"2021","unstructured":"Chen, J. et al. ACSL4 reprograms fatty acid metabolism in hepatocellular carcinoma via c-Myc\/SREBP1 pathway. Cancer Lett. 502, 154\u2013165. https:\/\/doi.org\/10.1016\/j.canlet.2020.12.019 (2021).","journal-title":"Cancer Lett."},{"key":"131_CR24","doi-asserted-by":"publisher","first-page":"23521","DOI":"10.1016\/S0021-9258(18)54312-X","volume":"266","author":"A Seth","year":"1991","unstructured":"Seth, A., Alvarez, E., Gupta, S. & Davis, R. J. A phosphorylation site located in the NH2-terminal domain of c-Myc increases transactivation of gene expression. J. Biol. Chem. 266, 23521\u201323524. https:\/\/doi.org\/10.1016\/S0021-9258(18)54312-X (1991).","journal-title":"J. Biol. Chem."},{"issue":"5","key":"131_CR25","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.3390\/cells10051056","volume":"10","author":"C Schiliro","year":"2021","unstructured":"Schiliro, C. & Firestein, B. L. Mechanisms of metabolic reprogramming in Cancer cells supporting enhanced growth and proliferation. Cells 10 (5), 1056. https:\/\/doi.org\/10.3390\/cells10051056 (2021).","journal-title":"Cells"},{"key":"131_CR26","first-page":"95","volume":"32","author":"AK Ferreira","year":"2012","unstructured":"Ferreira, A. K. et al. Anticancer effects of synthetic phosphoethanolamine on Ehrlich Ascites tumor: an experimental study. Anticancer Res. 32, 95\u2013104 (2012).","journal-title":"Anticancer Res."},{"key":"131_CR27","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1097\/01.mco.0000232894.28674.30","volume":"9","author":"JV Swinnen","year":"2006","unstructured":"Swinnen, J. V., Brusselmans, K. & Verhoeven, G. Increased lipogenesis in cancer cells: new players, novel targets. Curr. Opin. Clin. Nutr. Metab. Care. 9, 358\u2013365. https:\/\/doi.org\/10.1097\/01.mco.0000232894.28674.30 (2006).","journal-title":"Curr. Opin. Clin. Nutr. Metab. Care"},{"key":"131_CR28","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.bbcan.2010.01.005","volume":"1805","author":"E Furuta","year":"2010","unstructured":"Furuta, E., Okuda, H., Kobayashi, A. & Watabe, K. Metabolic genes in cancer: their roles in tumor progression and clinical implications. Biochim. Biophys. Acta. 1805, 141\u2013152. https:\/\/doi.org\/10.1016\/j.bbcan.2010.01.005 (2010).","journal-title":"Biochim. Biophys. Acta"},{"key":"131_CR29","doi-asserted-by":"publisher","first-page":"18891","DOI":"10.18632\/oncotarget.3783","volume":"6","author":"YY Zaytseva","year":"2015","unstructured":"Zaytseva, Y. Y. et al. Increased expression of fatty acid synthase provides a survival advantage to colorectal cancer cells via upregulation of cellular respiration. Oncotarget 6, 18891\u201318904. https:\/\/doi.org\/10.18632\/oncotarget.3783 (2015).","journal-title":"Oncotarget"},{"key":"131_CR30","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1016\/j.bbabio.2010.10.022","volume":"1807","author":"LS Pike","year":"2011","unstructured":"Pike, L. S., Smift, A. L., Croteau, N. J., Ferrick, D. A. & Wu, M. Inhibition of fatty acid oxidation by etomoxir impairs NADPH production and increases reactive oxygen species resulting in ATP depletion and cell death in human glioblastoma cells. Biochim. Biophys. Acta. 1807, 726\u2013734. https:\/\/doi.org\/10.1016\/j.bbabio.2010.10.022 (2011).","journal-title":"Biochim. Biophys. Acta"},{"key":"131_CR31","doi-asserted-by":"publisher","first-page":"12647","DOI":"10.1074\/jbc.M109.084194","volume":"285","author":"W Hao","year":"2010","unstructured":"Hao, W., Chang, C. P., Tsao, C. C. & Xu, J. Oligomycin-induced bioenergetic adaptation in cancer cells with heterogeneous bioenergetic organization. J. Biol. Chem. 285, 12647\u201312654. https:\/\/doi.org\/10.1074\/jbc.M109.084194 (2010).","journal-title":"J. Biol. Chem."},{"key":"131_CR32","doi-asserted-by":"publisher","unstructured":"Navarro, C. et al. Metabolic Reprogramming in Cancer Cells: Emerging Molecular Mechanisms and Novel Therapeutic Approaches. Pharmaceutics 14, 1303. (2022). https:\/\/doi.org\/10.3390\/pharmaceutics14061303","DOI":"10.3390\/pharmaceutics14061303"},{"key":"131_CR33","doi-asserted-by":"publisher","first-page":"11960","DOI":"10.1073\/pnas.0904875106","volume":"106","author":"K Mitra","year":"2009","unstructured":"Mitra, K., Wunder, C., Roysam, B., Lin, G. & Lippincott-Schwartz, J. A hyperfused mitochondrial state achieved at G1-S regulates Cyclin E buildup and entry into S phase. Proc. Natl. Acad. Sci. U S A. 106, 11960\u201311965. https:\/\/doi.org\/10.1073\/pnas.0904875106 (2009).","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"131_CR34","doi-asserted-by":"publisher","first-page":"7482","DOI":"10.1039\/d2sc02024f","volume":"13","author":"YW Xue","year":"2022","unstructured":"Xue, Y. W., Itoh, H., Dan, S., Inoue, M. & Gramicidin A accumulates in mitochondria, reduces ATP levels, induces mitophagy, and inhibits cancer cell growth. Chem. Sci. 13, 7482\u20137491. https:\/\/doi.org\/10.1039\/d2sc02024f (2022).","journal-title":"Chem. Sci."},{"issue":"1","key":"131_CR35","doi-asserted-by":"publisher","first-page":"5222","DOI":"10.1038\/s41598-021-84538-6","volume":"11","author":"A Schcolnik-Cabrera","year":"2021","unstructured":"Schcolnik-Cabrera, A. et al. Pharmacological Inhibition of tumor anabolism and host catabolism as a cancer therapy. Sci. Rep. 11 (1), 5222. https:\/\/doi.org\/10.1038\/s41598-021-84538-6 (2021).","journal-title":"Sci. Rep."},{"key":"131_CR36","doi-asserted-by":"publisher","first-page":"6909","DOI":"10.3892\/ol.2019.11008","volume":"18","author":"A Schcolnik-Cabrera","year":"2019","unstructured":"Schcolnik-Cabrera, A. et al. A combination of inhibitors of glycolysis, Glutaminolysis and de Novo fatty acid synthesis decrease the expression of chemokines in human colon cancer cells. Oncol. Lett. 18, 6909\u20136916. https:\/\/doi.org\/10.3892\/ol.2019.11008 (2019).","journal-title":"Oncol. Lett."},{"key":"131_CR37","doi-asserted-by":"publisher","first-page":"9157","DOI":"10.1073\/pnas.1317630111","volume":"111","author":"M Janghorban","year":"2014","unstructured":"Janghorban, M. et al. Targeting c-MYC by antagonizing PP2A inhibitors in breast cancer. Proc. Natl. Acad. Sci. U S A. 111, 9157\u20139162. https:\/\/doi.org\/10.1073\/pnas.1317630111 (2014).","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"131_CR38","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/j.molcel.2006.01.009","volume":"21","author":"B Benassi","year":"2006","unstructured":"Benassi, B. et al. c-Myc phosphorylation is required for cellular response to oxidative stress. Mol. Cell. 21, 509\u2013519. https:\/\/doi.org\/10.1016\/j.molcel.2006.01.009 (2006).","journal-title":"Mol. Cell."},{"key":"131_CR39","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/0076-6879(67)12127-7","volume":"12","author":"K Burton","year":"1968","unstructured":"Burton, K. [105] determination of DNA concentration with diphenylamine. Methods Enzymol. 12, 163\u2013166. https:\/\/doi.org\/10.1016\/0076-6879(67)12127-7 (1968).","journal-title":"Methods Enzymol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-00131-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-00131-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-00131-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T02:22:31Z","timestamp":1746152551000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-00131-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,2]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["131"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-00131-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,2]]},"assertion":[{"value":"8 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"15317"}}